Prospective evaluation of ERCP performance in an Italian regional database study

Mariani, Alberto; Segato, S.; Anderloni, Andrea; Cengia, Gianpaolo; Parravicini, M.; Staiano, Teresa; Tontini, Gian Eugenio; Lochis, Davide; Cantù, P.; Manfredi, Guido; Amato, Arnaldo; Bargiggia, S.; Bernasconi, Giordano; Lella, F.; Canani, M. Berni; Beretta, P; Ferraris, L.; Signorelli, Sergio; Pantaleo, Giuseppe; Manes, Gianpiero; Testoni, Pier Alberto; Prada, Alberto; Iiritano, E.; Lesinigo, E.; Mezzi, Gianni; Nucci, Germana de

doi:10.1016/j.dld.2018.12.021

Cited by 29 publications

(27 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…PEP occurred at a very low rate (2.9 %) and no cases were severe, which met the European Society of Gastrointestinal Endoscopy (ESGE) performance measure target of < 10 % [10]. The bleeding rate (2.0 %) was a little higher than the ASGE post-procedural indicator of < 1 % [11], but comparable to all of the most recent reports (up to 3.6 %) [12,13], and there were no severe cases. The rate of perforation was 0.5 %, again higher than the ASGE indicator of < 0.2 % but comparable to the 0.6% rate in an Austrian survey [12].…”

Section: Discussionsupporting

confidence: 73%

A multicenter survey on endoscopic retrograde cholangiopancreatography during the COVID-19 pandemic in northern and central Italy

et al. 2021

Self Cite

View full text Add to dashboard Cite

Background and study aims COVID-19 has dramatically impacted endoscopy practice because upper endoscopy procedures can be aerosol-generating. Most elective procedures have been rescheduled. Endoscopic retrograde cholangiopancreatography (ERCP) is frequently performed in emergency or urgent settings in which rescheduling is not possible. We evaluated the impact of the COVID-19 pandemic on ERCP in Italy during the SARS-CoV-2 lockdown, in areas with high incidence of COVID-19. Patients and methods We performed a retrospective survey of centers performing ERCP in high COVID-19 prevalence areas in Italy to collect information regarding clinical data from patients undergoing ERCP, staff, case-volume and organization of endoscopy units from March 8, 2020 to April 30, 2020. Results We collected data from 31 centers and 804 patients. All centers adopted a triage and/or screening protocol for SARS-CoV-2 and performed follow-up of patients 2 weeks after the procedure. ERCP case-volume was reduced by 44.1 % compared to the respective 2019 timeframe. Of the 804 patients undergoing ERCP, 22 (2.7 %) were positive for COVID-19. Adverse events occurred at a similar rate to previously published data. Of the patients, endoscopists, and nurses, 1.6 %, 11.7 %, and 4.9 %, respectively, tested positive for SARS-CoV-2 at follow up. Only 38.7 % of centers had access to a negative-pressure room for ERCP. Conclusion The case-volume reduction for ERCP during lockdown was lower than for other gastrointestinal endoscopy procedures. No definitive conclusions can be drawn about the percentage of SARS-CoV-2-positive patients and healthcare workers observed after ERCP. Appropriate triage and screening of patients and adherence to society recommendations are paramount.

show abstract

Section: Discussionsupporting

confidence: 73%

A multicenter survey on endoscopic retrograde cholangiopancreatography during the COVID-19 pandemic in northern and central Italy

et al. 2021

Self Cite

View full text Add to dashboard Cite

show abstract

“…Reportedly, the ERCP-induced complication and mortality rates are 5-10 and 0.1%-1%, respectively [1][2][3][4][5]. The most common post-procedural complication is post-ERCP pancreatitis (prevalence rate 1-15%) [3,21,22].…”

Section: Discussionmentioning

confidence: 99%

“…Endoscopic retrograde cholangiopancreatography (ERCP) is a complex and time-consuming procedure necessitating adequate sedation or general anesthesia. Reportedly, complication and mortality rates associated with ERCP are 5-10% and 0.1-1%, respectively [1][2][3][4][5]. Complications of ERCP include acute pancreatitis, bleeding, and perforation [1].…”

Section: Introductionmentioning

confidence: 99%

Sedation-related complications during anesthesiologist-administered sedation for endoscopic retrograde cholangiopancreatography: a prospective study

et al. 2020

View full text Add to dashboard Cite

Background: Patients undergoing endoscopic retrograde cholangiopancreatography (ERCP) require adequate sedation or general anesthesia. To date, there is lack of consensus regarding who should administer sedation in these patients. Several studies have investigated the safety and efficacy of non-anesthesiologist-administered sedation for ERCP; however, data regarding anesthesiologist-administered sedation remain limited. This prospective single-center study investigated the safety and efficacy of anesthesiologist-administered sedation and the rate of successful performed ERCP procedures. Methods: The study included 200 patients who underwent ERCP following anesthesiologist-administered sedation with propofol and remifentanil. Procedural data, oxygen saturation, systolic blood pressure (SBP), heart rate, recovery score, patient and endoscopist satisfaction, as well as 30-day mortality and morbidity data were analyzed. Results: Sedation-related complications occurred in 36 of 200 patients (18%) and included hypotension (SBP < 90 mmHg) and hypoxemia (O 2 saturation < 90%) in 18 patients (9%) each. Most events were minor and did not necessitate discontinuation of the procedure. However, ERCP was terminated in 2 patients (1%) secondary to sedation-related complications. Successful cannulation was performed in all patients. The mean duration of the examination was 25 ± 16 min. Mean recovery time was 14 ± 10 min, and high post-procedural satisfaction was observed in both, patients (mean visual analogue scale [VAS] 9.6 ± 0.8) and endoscopists (mean VAS 9.3 ± 1.3). Conclusion: This study suggests that anesthesiologist-administered sedation is safe in patients undergoing ERCP and is associated with a high rate of successful ERCP, shorter procedure time, and more rapid post-anesthesia recovery, with high patient and endoscopist satisfaction.

show abstract

“…Many studies have been performed to evaluate ERCP outcomes in terms of success rates and complications. In 2019, Mariani et al 4 reported a total of 2388 cases of ERCP, in which biliary cannulation was achieved in 2293 cases. They reported a success rate of 91.1% and concluded that ERCP can be safely performed by skilled endoscopists.…”

Section: Discussionmentioning

confidence: 99%

Evaluation of Safety and Outcomes of Endoscopic Retrograde Cholangiopancreatography in 1337 Patients at a Single Center

Kılıç¹,

Kahraman²,

Özdil³

2019

MMJ

View full text Add to dashboard Cite

Objective: Endoscopic retrograde cholangiopancreatography (ERCP) is the gold standard treatment for pancreaticobiliary diseases. The aim of this study was to evaluate the safety and review the outcomes of our experience of ERCP over the past 4 years. Method: The clinical records of patients aged 18-104 years who underwent ERCP at our gastroenterology clinic between 2014 and 2018 were included in the study. Data were acquired from the hospital archive system. Results: A total of 1337 patients with a mean age of 60.58±17.96 years. including 775 female, and 562 male cases were included in the study. The patients were in the age groups of 18-30 (n=39), 30-65 (n=694), 65-75 (n=274), 75-85 (n=258), and > 85 (n=72) years. Among them, 28.27% were rated as ASA III-IV on the American Society of Anesthesiologists scale. Although biliary cannulation with standard sphincterotomy was successful in 1303 (97.45%), patients it could not be performed in 34 (2.55%). patients Precut papillotomy was performed in 27 (79.41%) of 34 patients. Furthermore, no complication was observed in 1207 patients (90.27%), whereas 96 patients (7.18%) had minor and major procedure-related and anesthesia-related complications. The 30-day mortality rate was 1.64% (n=22). Conclusion: We concluded that ERCP, which is currently performed entirely for therapeutic purposes, is safe and lifesaving, with high clinical success rates.

show abstract

Prospective evaluation of ERCP performance in an Italian regional database study

Cited by 29 publications

References 36 publications

A multicenter survey on endoscopic retrograde cholangiopancreatography during the COVID-19 pandemic in northern and central Italy

A multicenter survey on endoscopic retrograde cholangiopancreatography during the COVID-19 pandemic in northern and central Italy

Sedation-related complications during anesthesiologist-administered sedation for endoscopic retrograde cholangiopancreatography: a prospective study

Evaluation of Safety and Outcomes of Endoscopic Retrograde Cholangiopancreatography in 1337 Patients at a Single Center

Contact Info

Product

Resources

About